The effect of Althadin tabet in the sore throat of larangeal mask airway

The effect of Althadin tabet in the sore throat of patients undergoing cataract surgery after insertion of larangeal mask airway

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211120053110N1

Enrollment

239

Registered

2022-01-03

Start date

2021-04-30

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sore throat.

Interventions

Intervention group received an Althadine sucking tablet 30 min before the start of surgery.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who undergoing Cataract surgery for less than 60 min (between 40 and 60 min) Do not have diabetes Do not have hypertention

Exclusion criteria

Exclusion criteria: Patients with upper airway abnormalities Patients with asthma, sore throat, pharyngitis, and neuromuscular and mental-psychological problems so that the desired outcomes could not be evaluated Obesity (BMI>35) Drug or cigarette addiction Drug allergies Those in whom the first attempt to insert a laryngeal mask is unsuccessful.

Design outcomes

Primary

Measure	Time frame
Rate of sore throat base on visual analog scale. Timepoint: 1,3,6,12,24 hours after surgery. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Alipour

Mashhad University of Medical Sciences

alipourm@mums.ac.ir+98 51 3840 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026